Bruce L Levine

Citirano

	Sve	Od 2018.
Citati	62565	38757
H-indeks	105	72
i10-indeks	247	198

9000

4500

2250

6750

19981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023219 240 262 272 251 292 297 439 503 561 640 596 679 842 1196 1779 2357 3081 3981 4411 5449 6430 7651 8366 7803 2942

Javni pristup

Prikaži sve

109 članaka

7 članaka

dostupno

nije dostupno

Na temelju uvjeta financiranja

Suautori

Carl JuneUniversity of PennsylvaniaPotvrđena adresa e-pošte na upenn.edu
Stephan A. GruppProfessor of Pediatrics, University of Pennsylvania School of MedicinePotvrđena adresa e-pošte na email.chop.edu
Jim RileyUniversity of PennsylvaniaPotvrđena adresa e-pošte na upenn.edu
Pamela A. ShawKaiser Permanente Washington Health Research InstitutePotvrđena adresa e-pošte na kp.org
Wei-Ting HwangProfessor of Biostatistics, University of PennsylvaniaPotvrđena adresa e-pošte na upenn.edu
Jakub SvobodaUniversity of PennsylvaniaPotvrđena adresa e-pošte na uphs.upenn.edu
Yangbing ZhaoUTC Therapeutics.IncPotvrđena adresa e-pošte na utctherapeutics.com
John E. WagnerUniversity of MinnesotaPotvrđena adresa e-pošte na umn.edu
George CoukosUniversity Hospital of Lausanne, Ludwig Institute for Cancer ResearchPotvrđena adresa e-pošte na chuv.ch
Anthony MatoCLL Program at Memorial Sloan Kettering Cancer CenterPotvrđena adresa e-pošte na mskcc.org
Yolanda D MahnkeUniversity of PennsylvaniaPotvrđena adresa e-pošte na uphs.upenn.edu
Brendan WeissAbramson Cancer Center, University of PennsylvaniaPotvrđena adresa e-pošte na uphs.upenn.edu
Pablo TebasUniversity of PennsylvaniaPotvrđena adresa e-pošte na uphs.upenn.edu
Craig ThompsonMemorial Sloan Kettering Cancer CenterPotvrđena adresa e-pošte na mskcc.org
Ashraf BadrosProfessor of Medicine; University of MarylandPotvrđena adresa e-pošte na umm.edu
Michael SoulenProfessor of Radiology & Surgery, University of PennsylvaniaPotvrđena adresa e-pošte na uphs.upenn.edu
Lin ZhangHarry Fields Research Professor, University of Pennsylvania School of MedicinePotvrđena adresa e-pošte na mail.med.upenn.edu
MALA TALEKARMedical Director, Oncology Clinical Development, GSK; Attending Physician, Children's Hosp ofPotvrđena adresa e-pošte na gsk.com
Troy BradyUniversity of Pennsylvania, Iowa State UniversityPotvrđena adresa e-pošte na auburn.edu
Marco Ruella, MDUniversity of PennsylvaniaPotvrđena adresa e-pošte na upenn.edu

Prati

Bruce L Levine

Barbara and Edward Netter Professor in Cancer Gene Therapy, Department of Pathology and Laboratory

Potvrđena adresa e-pošte na pennmedicine.upenn.edu


Naslov Poredaj po navodima Poredaj po godini Poredaj po naslovu	Citirano Citirano	Godina
Chimeric antigen receptor T cells for sustained remissions in leukemia SL Maude, N Frey, PA Shaw, R Aplenc, DM Barrett, NJ Bunin, A Chew, ... New England Journal of Medicine 371 (16), 1507-1517, 2014	5107	2014
Chimeric antigen receptor–modified T cells in chronic lymphoid leukemia DL Porter, BL Levine, M Kalos, A Bagg, CH June N engl j Med 365, 725-733, 2011	4102	2011
Tisagenlecleucel in children and young adults with B-cell lymphoblastic leukemia SL Maude, TW Laetsch, J Buechner, S Rives, M Boyer, H Bittencourt, ... New England Journal of Medicine 378 (5), 439-448, 2018	3731	2018
Chimeric antigen receptor–modified T cells for acute lymphoid leukemia SA Grupp, M Kalos, D Barrett, R Aplenc, DL Porter, SR Rheingold, ... New England Journal of Medicine 368 (16), 1509-1518, 2013	3716	2013
T cells with chimeric antigen receptors have potent antitumor effects and can establish memory in patients with advanced leukemia M Kalos, BL Levine, DL Porter, S Katz, SA Grupp, A Bagg, CH June Science translational medicine 3 (95), 95ra73-95ra73, 2011	2927	2011
Chimeric antigen receptor T cells persist and induce sustained remissions in relapsed refractory chronic lymphocytic leukemia DL Porter, WT Hwang, NV Frey, SF Lacey, PA Shaw, AW Loren, A Bagg, ... Science translational medicine 7 (303), 303ra139-303ra139, 2015	1615	2015
Gene editing of CCR5 in autologous CD4 T cells of persons infected with HIV P Tebas, D Stein, WW Tang, I Frank, SQ Wang, G Lee, SK Spratt, ... New England Journal of Medicine 370 (10), 901-910, 2014	1584	2014
Chimeric antigen receptor T cells in refractory B-cell lymphomas SJ Schuster, J Svoboda, EA Chong, SD Nasta, AR Mato, Ö Anak, ... New England Journal of Medicine 377 (26), 2545-2554, 2017	1449	2017
A single dose of peripherally infused EGFRvIII-directed CAR T cells mediates antigen loss and induces adaptive resistance in patients with recurrent glioblastoma DM O’Rourke, MLP Nasrallah, A Desai, JJ Melenhorst, K Mansfield, ... Science translational medicine 9 (399), eaaa0984, 2017	1233	2017
Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics CG Brunstein, JS Miller, Q Cao, DH McKenna, KL Hippen, J Curtsinger, ... Blood, The Journal of the American Society of Hematology 117 (3), 1061-1070, 2011	1141	2011
Cardiovascular toxicity and titin cross-reactivity of affinity-enhanced T cells in myeloma and melanoma GP Linette, EA Stadtmauer, MV Maus, AP Rapoport, BL Levine, L Emery, ... Blood, The Journal of the American Society of Hematology 122 (6), 863-871, 2013	1101	2013
Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemia JA Fraietta, SF Lacey, EJ Orlando, I Pruteanu-Malinici, M Gohil, S Lundh, ... Nature medicine 24 (5), 563-571, 2018	1054	2018
Engineered T cells: the promise and challenges of cancer immunotherapy AD Fesnak, CH June, BL Levine Nature reviews cancer 16 (9), 566-581, 2016	1038	2016
CRISPR-engineered T cells in patients with refractory cancer EA Stadtmauer, JA Fraietta, MM Davis, AD Cohen, KL Weber, E Lancaster, ... Science 367 (6481), eaba7365, 2020	875	2020
NY-ESO-1–specific TCR–engineered T cells mediate sustained antigen-specific antitumor effects in myeloma AP Rapoport, EA Stadtmauer, GK Binder-Scholl, O Goloubeva, DT Vogl, ... Nature medicine 21 (8), 914-921, 2015	871	2015
Identification of predictive biomarkers for cytokine release syndrome after chimeric antigen receptor T-cell therapy for acute lymphoblastic leukemia DT Teachey, SF Lacey, PA Shaw, JJ Melenhorst, SL Maude, N Frey, ... Cancer discovery 6 (6), 664-679, 2016	838	2016
Mesothelin-Specific Chimeric Antigen Receptor mRNA-Engineered T Cells Induce Antitumor Activity in Solid MalignanciesCase Report: RNA CAR T Cells GL Beatty, AR Haas, MV Maus, DA Torigian, MC Soulen, G Plesa, ... Cancer immunology research 2 (2), 112-120, 2014	823	2014
Decade-long safety and function of retroviral-modified chimeric antigen receptor T cells J Scholler, TL Brady, G Binder-Scholl, WT Hwang, G Plesa, KM Hege, ... Science translational medicine 4 (132), 132ra53-132ra53, 2012	700	2012
Identification of a Titin-derived HLA-A1–presented peptide as a cross-reactive target for engineered MAGE A3–directed T cells BJ Cameron, AB Gerry, J Dukes, JV Harper, V Kannan, FC Bianchi, ... Science translational medicine 5 (197), 197ra103-197ra103, 2013	635	2013
Gene transfer in humans using a conditionally replicating lentiviral vector BL Levine, LM Humeau, J Boyer, RR MacGregor, T Rebello, X Lu, ... Proceedings of the National Academy of Sciences 103 (46), 17372-17377, 2006	609	2006

Sustav trenutno ne može provesti ovu radnju. Pokušajte ponovo kasnije.

Članci 1–20

Godišnji broj citata

Dvostruki navodi

Spojeni navodi

Dodavanje suautoraSuautori

Prati

Citirano

Suautori